ClinicalTrials.gg
RecruitingNCT05883618GNOS SpineUpdated Jun 1, 2023

Global Neurotrauma Outcomes Study: Spine

An observational study in Spine Injury and Trauma, sponsored by University of Cambridge. Recruiting at 1 site in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-06-01.

Sponsored by University of Cambridge · Observational

From the registry’s dates

  • Primary completion was expected by May 2023, 3 years 5 months ago, but the record still lists the study as recruiting.
  • Started Jul 2021; still recruiting 5 years 4 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
1,000
Ages
18 Years and older
Sex
All
01

Study summary

Primary aim:

Characterise case-mix, processes of care and variations in nonoperative and operative management strategies, including emergency, ward, surgical and ICU care, in patients presenting with traumatic spinal injury (TSI) between centres across low and high Human Development Index (HDI) countries.

Primary outcome measure:

The primary outcome measure will be Frankel Grade at 6 weeks post-admission (or discharge, whichever comes first).

Primary comparison:

Between country groups defined by human development index

Centre eligibility:

Any unit assessing patients with TSI worldwide will be eligible to participate

Patient eligibility:

All adult patients presenting with radiologically confirmed traumatic spinal injury.

Team:

Each participating unit will form a study team of up to four investigators including a study lead, local investigator 1/2 and an independent data validator.

Time period:

Local study teams may select any 30-day period from July 12th 2021 to start their study. Patients who meet the inclusion criteria between 00:01 on day 0 and 23:59 on day 30 of the selected study period will be included.

Validation:

There will be a two-phase data validation process. Phase 1 will be prospective, validating case ascertainment, and phase 2 will be retrospective, validating operative data.

Read the detailed description

Background Traumatic spinal injury (TSI) accounts for a significant proportion of disability and death worldwide, with the majority of this burden affecting individuals in low- to middle- income countries. Crucially, to date, the current disease profile of TSI has not been characterised globally. In addition, the global approach to the care of patients following TSI is inconsistent with considerable geographical differences in process of care reported, and limited data available on the impact of these variations on outcomes following TSI. A better understanding of case-mix and processes of care is urgently needed to underpin efforts to identify ways of improving outcome relevant to different socioeconomic settings globally.

Objectives The primary objective of this study is to characterise the case-mix, processes of care and variations in nonoperative and operative management strategies, including emergency, ward, ICU care, in patients presenting with traumatic spinal injury (TSI) between centres across low and high Human Development Index (HDI) countries. The secondary aims are to summarise current local resources and management pathways for TSI through validation of provider profiling data, describe differences in indications for nonoperative and operative management, and short-term outcomes following TSI. This study aims to identify gaps in processes of care to identify targets for future interventions to improve TSI care across high and low-resource settings.

Methods A multi-centre, international, prospective, observational study. Any unit assessing patients with TSI worldwide will be eligible to participate. Each participating unit will form a study team responsible for gaining local approval, identifying patients for inclusion and conducting data collection. Data will be collected via a secure online platform in an anonymised form. Processes of care will be characterised by a detailed provider profiling exercise. A registry describing the case-mix and care of all adults presenting with radiologically confirmed TSI will be collected, in a given consecutive 30-day period during the study period starting in 2021.

Results The dataset, developed through an iterative feedback process involving clinicians from low and high Human Development Index (HDI) countries, includes patient demographics, details of injury mechanism, local injury management and, if applicable, timing and nature of surgery, post-operative care and immediate postoperative complications. Outcome measures include Frankel grade at 6 weeks post-admission (or at discharge or death, whichever event occurs first), early mortality, peri-operative complications, adverse events of special interest, functional status and mobility. Descriptive analyses of case-mix and the variations in processes of care will be conducted. Available resources, use of guidelines and variations in processes of care will be characterised using both provider profiling responses and patient-level data collected. Areas where known best practice is deficient or unavailable will be identified as potential targets for future implementation studies.

Conclusions GNOS Spine aims to provide a global snapshot of the case-mix, management, processes of care and short-term outcomes of patients presenting with TSI. In addition, the study aims to identify areas for further study, and establish a platform and clinical network to facilitate this future research in global neurotrauma and spinal surgery.

02

Conditions studied

  • Spine Injury
  • Trauma

Keywords

  • Traumatic spine injury
  • Global burden
03

In context

Spinal Injuries

57 studies on the registry are indexed under Spinal Injuries; 15 are open to participants now.

This study's planned enrollment of 1,000 is above the median of 92 across 22 observational studies indexed under Spinal Injuries.

Browse Spinal Injuries studies →

Lead sponsor

University of Cambridge is the lead sponsor of 116 studies on the registry; 23 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

All adult patients with radiologically confirmed traumatic spine injury

Eligibility criteria

Centre inclusion Criteria

  • Any primary, secondary or tertiary institution worldwide managing patients with TSI is eligible to participate.
  • In many institutions, management for TSI may be provided by spinal surgeons - however, centres in which management for TSI is provided by general surgeons, trauma surgeons, general medical doctors or even non-physician clinicians are also eligible to participate.

Patient inclusion and exclusion criteria Inclusion Criteria

  • All adult patients presenting to the participating institution with a first presentation of TSI confirmed radiographically, during the selected 30-day inclusion period are eligible for inclusion in the core study.

Exclusion Criteria

  • Elective (planned) or semi-elective (patient initially discharged after emergency with planned
  • intervention at a future date) admissions
  • Patients who have previously had an admission for TSI rendering them eligible for inclusion in this study (regardless of whether they were included on the previous admission or not)
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
1,000 participants (estimated)
Patient registry
No

Groups and cohorts

  • Radiologically confirmed traumatic spine injury

    Other: Exposure

Interventions

  • OtherExposure

    Human Development Index of Country

06

What researchers measure

Primary outcomes

  1. Frankel Grade

    A = complete motor and sensory loss (poor outcome), E = no neurological symptoms or signs (good outcome)

    Time frame: At discharge or 6 weeks post-admission, whichever comes first

Secondary outcomes

  1. Mortality

    Assessment of survival

    Time frame: At discharge or 6 weeks post-admission, whichever comes first

  2. Length of Stay

    Hospital and ICU

    Time frame: At discharge or at 6 weeks post-admission (whichever comes first)

  3. Peri-operative Complications

    Return to operating theatre, surgical site infections, adverse events of special interest (pressure ulcer, pneumonia, DVT)

    Time frame: At discharge or at 6 weeks post-admission (whichever comes first)

  4. Independence with activities of daily living (ADLs)

    Rating of specific ADLs as unaided, with aid or completely dependent

    Time frame: At discharge or at 6 weeks post-admission (whichever comes first)

  5. Mobility

    Mechanism of mobility e.g. mobilising independently, mobilising with a frame, wheelchair, bed bound etc.)

    Time frame: At discharge or at 6 weeks post-admission (whichever comes first)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Yes — After publication of the main results, the pooled dataset will be available to all members of the GNOS Spine collaboration for secondary analysis, after judgement and approval of each proposed analysis by the central study team.

Supporting information: Study protocol, Statistical analysis plan

Time frame: Following publication of the main results

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 1, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05883618
Collaborators
NIHR Global Health Research Group on Neurotrauma
Responsible party
Saniya Mediratta (Co-Principle Investigator, University of Cambridge) — Principal investigator
First posted
Jun 1, 2023
Start date
Jul 12, 2021
Primary completion
May 30, 2023 (estimated)
Completion
May 30, 2023 (estimated)
Last update
Jun 1, 2023

Study contacts

Saniya Mediratta
Contact
info@globalspinetrauma.com
+441223336946
Rikin Trivedi
Contact
info@globalspinetrauma.com
+441223336946
Saniya Mediratta
principal investigator · NIHR Global Health Research Group on Neurotrauma
Jibin Francis
principal investigator · NIHR Global Health Research Group on Neurotrauma
Peter Hutchinson
principal investigator · NIHR Global Health Research Group on Neurotrauma
Rikin Trivedi
principal investigator · NIHR Global Health Research Group on Neurotrauma

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion